Every Cure, a Philadelphia-based nonprofit, has been awarded a $48.3 million federal contract to develop an AI-driven program aimed at repurposing existing medications for rare diseases. This innovative approach will utilize algorithms to analyze thousands of approved drugs and identify potential new uses, streamlining a traditionally slow process. The initiative is backed by the Advanced Research Projects Agency for Health, which seeks to accelerate medical breakthroughs.
The project aims to create an open-source database and a portal for medical professionals and patients to contribute ideas. By generating predictive efficacy scores, Every Cure will evaluate which drugs have the highest potential for repurposing, ultimately recommending candidates for clinical trials. This could revolutionize treatment options for patients with rare diseases, highlighting the untapped potential of existing medications.
• Every Cure aims to automate drug repurposing using AI algorithms.
• The project will create a database for drug repurposing and patient input.
In this context, AI is used to analyze drug data and identify new treatment possibilities.
This scoring will guide decisions on which drugs to consider for further clinical trials.
Every Cure is leveraging AI to find new uses for existing medications, aiming to improve treatment options for rare diseases.
The agency supports projects like Every Cure's to expedite breakthroughs in medical treatments.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.